PYRIDOPYRIMIDINES AS HISTAMINE H4-RECEPTOR INHIBITORS

The invention relates to compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor. 本发明涉及式(I)化合物或其药学上可接受的盐或溶剂化物，涉及包含它...

Full description

Saved in:
Bibliographic Details
Main Authors OLIVERA TIZNE ROBERTO, NOVERGES PEDRO BARBARA, ZAZPE ARCE ARTURO, TATO CERDEIRAS PALOMA, HERNANDEZ HERRERO GONZALO, CORCOSTEGUI VIVAR REYES, GARCIA DOMINGUEZ NEFTALI
Format Patent
LanguageChinese
English
Published 30.04.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor. 本发明涉及式(I)化合物或其药学上可接受的盐或溶剂化物，涉及包含它们的药物组合物，以及它们在治疗和/或预防由组胺H4受体介导的疾病或病症中的用途。
Bibliography:Application Number: CN201980061408